| Dr Muhammad Akram, MD | |
|
800 Hospital Dr, Madisonville, KY 42431-1658 | |
| (270) 821-0677 | |
| (270) 326-3805 |
| Full Name | Dr Muhammad Akram |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 39 Years |
| Location | 800 Hospital Dr, Madisonville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902803737 | NPI | - | NPPES |
| 000000388817 | Other | KY | BCBS |
| 200336220A | Medicaid | IN | |
| 64035322 | Medicaid | KY | |
| 000000670614 | Other | KY | ANTHEM BCBS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Madisonville | Madisonville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Deaconess Medical Group Inc | 6103220330 | 126 |
News Archive
Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
Bruker AXS GmbH announced today that it has acquired the assets of Hecus X-ray Systems GmbH, a company focused on analytical instrumentation for Small Angle X-ray Scattering (SAXS) based on advanced Kratky technology.
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
› Verified 2 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
Bruker AXS GmbH announced today that it has acquired the assets of Hecus X-ray Systems GmbH, a company focused on analytical instrumentation for Small Angle X-ray Scattering (SAXS) based on advanced Kratky technology.
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
› Verified 2 days ago
| Entity Name | Baptist Health Deaconess Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437730942 PECOS PAC ID: 6103220330 Enrollment ID: O20210810000993 |
News Archive
Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
Bruker AXS GmbH announced today that it has acquired the assets of Hecus X-ray Systems GmbH, a company focused on analytical instrumentation for Small Angle X-ray Scattering (SAXS) based on advanced Kratky technology.
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muhammad Akram, MD 200 Clinic Dr, Madisonville, KY 42431-1661 Ph: (270) 821-0677 | Dr Muhammad Akram, MD 800 Hospital Dr, Madisonville, KY 42431-1658 Ph: (270) 821-0677 |
News Archive
Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
Bruker AXS GmbH announced today that it has acquired the assets of Hecus X-ray Systems GmbH, a company focused on analytical instrumentation for Small Angle X-ray Scattering (SAXS) based on advanced Kratky technology.
Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies.
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
› Verified 2 days ago
Deepak Kapadia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Hospital Dr, Suite B, Madisonville, KY 42431 Phone: 270-821-5454 Fax: 270-326-4968 | |
Devalkumar Jitendrabhai Rajyaguru, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-825-5800 Fax: 270-825-5810 | |
David A Ladden, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Hospital Dr, Madisonville, KY 42431 Phone: 270-326-3800 Fax: 270-326-3805 | |
Dr. Stacey Michelle Miller, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 | |
Dolph Martel Denny, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Madisonville, KY 42431 Phone: 270-326-3800 | |
Imran Dosani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1020 Waterfall Ct, Madisonville, KY 42431 Phone: 270-821-5726 | |
Tomas Rafael Higgins, Internal Medicine Medicare: Medicare Enrolled Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-825-5100 |